Fundraising
Sano Women’s Health Raises Funds to Advance Phase 2 Clinical Trials for Novel RVVC Treatment
Sano Women's Health
PR-06-25-NI-01Jun 06, 2025
Clinical Trials
Krystal Biotech Announces Positive Results from Phase 2 Clinical Trial and Receives Regenerative Medicine Advanced Therapy Designation
Krystal Biotech
PR-M06-19-NI-047Jun 25, 2019
Clinical Data
DNAtrix To Present Interim Phase 2 Results of DNX-2401 with Pembrolizumab for Glioblastoma
DNAtrix
PR-M11-18-NI-067Nov 20, 2018
Clinical Results
Theravance Biopharma Reports Positive Top-Line Four-Week Data from Phase 2 Trial of TD-9855 for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma
PR-M08-18-NI-031Aug 09, 2018
Clinical Trials
BioMarin Doses First Participant in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
BioMarin
PR-M06-18-NI-059Jun 18, 2018
Phase 2 Trial
Tenax Therapeutics Announces Study Design for Phase 2 Trial of Levosimendan in PH-HFpEF Patients
Tenax Therapeutics
PR-M06-18-NI-027Jun 08, 2018